Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06434662
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-10
Brief Title:
Mitoxantrone Hydrochloride Liposome Injection Cytarabine Combined With Venetoclax in the Treatment of RR AML
Sponsor:
First Affiliated Hospital of Zhejiang University
Organization:
First Affiliated Hospital of Zhejiang University
Organization Data
Organization:
First Affiliated Hospital of Zhejiang University
Class:
OTHER
Study ID:
CSPC-DED-AML-K13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| CSPC Zhongnuo Pharmaceutical Shijiazhuang Co Ltd | INDUSTRY |